FDA Device Intelligence
HomeTOYOBO CO., LTD. › Nerbridge®

Nerbridge®

TOYOBO CO., LTD. · Model RN04025E · UDI-DI 04965838907463

JXI
1
510(k) clearances
167
Adverse events
4
Recalls
38
Facilities

Description

Nerbridge® is a product composed of polyglycolic acid and collagen derived from porcine skin. Nerbridge® is a flexible, resorbable and semipermeable tubular membrane matrix filled with porous collagen that provides a non-constricting encasement for injured peripheral nerves for protection of the neural environment. Nerbridge® is designed to be an interface between the nerve and the surrounding tissue. When hydrated, Nerbridge® is an easy to handle, pliable, soft, non-friable, porous conduit. The resilience of Nerbridge® allows the product to recover and maintain closure without constricting the nerve once the device is placed around the nerve. Nerbridge® is manufactured using validated viral inactivation and removal processes for the collagen. The product is provided in a foil pouch, sterile, non-pyrogenic, for single use only, in a variety of sizes, and placed in an outer Tyvek header bag for added protection.

Recalls

DateFirmReason
2023-03-27Baxter Healthcare CorporationThe product is brittle and potentially crumbling upon handling or when being removed from its package.
2020-02-07Integra LifeSciences Corp.Nonconforming product which was dispositioned for rejection was mistakenly released for commercial use.
2013-03-28Integra LifeSciences CorporationDue to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.
2013-03-28Integra LifeSciences CorporationDue to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.